Sex | Group ID | Group | Exposure | Attachment time point (post-exposure) | Blood collection time point (post-exposure) | Fipronil sulfone (ng/ml) | Number of replete ticks successfully detaching |
---|---|---|---|---|---|---|---|
Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 96.3 | 0 |
Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 140.3 | 0 |
Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 222.7 | 0 |
Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 247.4 | 0 |
Male | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 361.9 | 0 |
Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 161.5 | 0 |
Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 234.7 | 0 |
Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 75.6 | 0 |
Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 134.4 | 0 |
Female | T24-1 | Treatment | 24 h | Day 1 | Day 5 | 239.7 | 0 |
Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 78.8 | 0 |
Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 15.5 | 0 |
Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | ND | 13 |
Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 12.7 | 0 |
Male | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 40.3 | 0 |
Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 18.8 | 0 |
Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 16.2 | 0 |
Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 4.4 | 0 |
Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 79.3 | 0 |
Female | T24-15 | Treatment | 24 h | Day 15 | Day 19 | 28.2 | 0 |
Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 32 | 0 |
Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 11.9 | 0 |
Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 25.7 | 0 |
Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 19.4 | 0 |
Male | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 8 |
Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 0 |
Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 4.8 | 1 |
Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 9 |
Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | ND | 2 |
Female | T168-21 | Treatment | 168 h | Day 21 | Day 25 | 11.8 | 0 |
Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | 8.8 | 0 |
Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 1 |
Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 5 |
Male | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 5 |
Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 2 |
Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 4 |
Female | T168-35 | Treatment | 168 h | Day 35 | Day 39 | ND | 3 |
Male | C24-1 | Control | NA | Day 1 | Day 5 | ND | 19 |
Female | C24-1 | Control | NA | Day 1 | Day 5 | ND | 10 |
Male | C168-35 | Control | NA | Day 35 | Day 39 | ND | 11 |
Female | C168-35 | Control | NA | Day 35 | Day 39 | ND | 7 |